on cnbc’s halftime report final trades joseph terranova of virtus investment partners said crispr therapeutics ag crsp reported strong quarterly earnings crispr therapeutics posted a q1 loss of 67 cents per share narrower than market expectations for a loss of 176 per share analysts have a consensus buy rating on csp according to benzingas analyst ratings data jenny harrington of gilman hill asset management said devon energy corporation dvn reported a great quarter on monday the company also increased its share repurchase authorization by 50 the oil producer reported adjusted earnings of 146 per share which beat estimates of 138 per share oil production averaged 320000 barrels per day in the quarter which came in 2000 barrels per day above the company’s midpoint guidance don’t forget to check out our premarket coverage here josh brown of ritholtz wealth management said he is feeling very good about berkshire hathaway inc’s nyse brkb succession warren buffetts berkshire reported a profit of 355 billion for the first quarter price action berkshire hathaway shares fell 04 to settle at 32487 on tuesday devon energy fell 36 to 4917 while crispr therapeutics jumped 133 to settle at 6342 on tuesday check this out wall streets most accurate analysts say hold these 3 financial stocks delivering highdividend yields